Kasichayanula S - Search Results

1

Influence of hepatic impairment on the pharmacokinetics and safety profile of dapagliflozin: an open-label, parallel-group, single-dose study.

Kasichayanula S, Liu X, Zhang W, Pfister M, LaCreta FP, Boulton DW. Kasichayanula S, et al. Clin Ther. 2011 Nov;33(11):1798-808. doi: 10.1016/j.clinthera.2011.09.011. Epub 2011 Oct 26. Clin Ther. 2011. PMID: 22030444 Clinical Trial.

2

Pharmacokinetics of gabapentin after a single day and at steady state following the administration of gastric-retentive- extended-release and immediate-release tablets: a randomized, open-label, multiple-dose, three-way crossover, exploratory study in healthy subjects.

Gordi T, Hou E, Kasichayanula S, Berner B. Gordi T, et al. Among authors: kasichayanula s. Clin Ther. 2008 May;30(5):909-16. doi: 10.1016/j.clinthera.2008.05.008. Clin Ther. 2008. PMID: 18555937 Clinical Trial.

3

In vitro characterization and pharmacokinetics of dapagliflozin (BMS-512148), a potent sodium-glucose cotransporter type II inhibitor, in animals and humans.

Obermeier M, Yao M, Khanna A, Koplowitz B, Zhu M, Li W, Komoroski B, Kasichayanula S, Discenza L, Washburn W, Meng W, Ellsworth BA, Whaley JM, Humphreys WG. Obermeier M, et al. Among authors: kasichayanula s. Drug Metab Dispos. 2010 Mar;38(3):405-14. doi: 10.1124/dmd.109.029165. Epub 2009 Dec 8. Drug Metab Dispos. 2010. PMID: 19996149 Clinical Trial.

4

Dapagliflozin treatment in patients with different stages of type 2 diabetes mellitus: effects on glycaemic control and body weight.

Zhang L, Feng Y, List J, Kasichayanula S, Pfister M. Zhang L, et al. Among authors: kasichayanula s. Diabetes Obes Metab. 2010 Jun;12(6):510-6. doi: 10.1111/j.1463-1326.2010.01216.x. Diabetes Obes Metab. 2010. PMID: 20518806 Clinical Trial.

5

Lack of pharmacokinetic interaction between dapagliflozin, a novel sodium-glucose transporter 2 inhibitor, and metformin, pioglitazone, glimepiride or sitagliptin in healthy subjects.

Kasichayanula S, Liu X, Shyu WC, Zhang W, Pfister M, Griffen SC, Li T, LaCreta FP, Boulton DW. Kasichayanula S, et al. Diabetes Obes Metab. 2011 Jan;13(1):47-54. doi: 10.1111/j.1463-1326.2010.01314.x. Diabetes Obes Metab. 2011. PMID: 21114603 Clinical Trial.

6

Pharmacokinetics and pharmacodynamics of dapagliflozin, a novel selective inhibitor of sodium-glucose co-transporter type 2, in Japanese subjects without and with type 2 diabetes mellitus.

Kasichayanula S, Chang M, Hasegawa M, Liu X, Yamahira N, LaCreta FP, Imai Y, Boulton DW. Kasichayanula S, et al. Diabetes Obes Metab. 2011 Apr;13(4):357-65. doi: 10.1111/j.1463-1326.2011.01359.x. Diabetes Obes Metab. 2011. PMID: 21226818 Clinical Trial.

7

Effect of a high-fat meal on the pharmacokinetics of dapagliflozin, a selective SGLT2 inhibitor, in healthy subjects.

Kasichayanula S, Liu X, Zhang W, Pfister M, Reele SB, Aubry AF, LaCreta FP, Boulton DW. Kasichayanula S, et al. Diabetes Obes Metab. 2011 Aug;13(8):770-3. doi: 10.1111/j.1463-1326.2011.01397.x. Diabetes Obes Metab. 2011. PMID: 21435141 Clinical Trial.

8

Quantification of 4-beta-hydroxycholesterol in human plasma using automated sample preparation and LC-ESI-MS/MS analysis.

Goodenough AK, Onorato JM, Ouyang Z, Chang S, Rodrigues AD, Kasichayanula S, Huang SP, Turley W, Burrell R, Bifano M, Jemal M, LaCreta F, Tymiak A, Wang-Iverson D. Goodenough AK, et al. Among authors: kasichayanula s. Chem Res Toxicol. 2011 Sep 19;24(9):1575-85. doi: 10.1021/tx2001898. Epub 2011 Jul 21. Chem Res Toxicol. 2011. PMID: 21728364

9

Lack of pharmacokinetic interactions between dapagliflozin and simvastatin, valsartan, warfarin, or digoxin.

Kasichayanula S, Chang M, Liu X, Shyu WC, Griffen SC, LaCreta FP, Boulton DW. Kasichayanula S, et al. Adv Ther. 2012 Feb;29(2):163-77. doi: 10.1007/s12325-011-0098-x. Epub 2012 Jan 19. Adv Ther. 2012. PMID: 22271159 Free article. Clinical Trial.

10

Simultaneous oral therapeutic and intravenous ¹⁴C-microdoses to determine the absolute oral bioavailability of saxagliptin and dapagliflozin.

Boulton DW, Kasichayanula S, Keung CF, Arnold ME, Christopher LJ, Xu XS, Lacreta F. Boulton DW, et al. Among authors: kasichayanula s. Br J Clin Pharmacol. 2013 Mar;75(3):763-8. doi: 10.1111/j.1365-2125.2012.04391.x. Br J Clin Pharmacol. 2013. PMID: 22823746 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

43 results

Search Page

Filters